Combination therapy to treat Mycobacterium diseases

Locher, C. P., Bennani, Y. L., Grillot, A. L., O'dowd, H., Perola, E., Le Tiran, A., & Charifson, P. S.

U.S. Patent No. 9,572,809. 21 Feb. 2017.

The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof wherein X and R are as defined herein. The compounds of formula (I) are useful as gyrase and/or topoisomerase IV inhibitors for treating bacterial infections. The compounds of formula (I) either possess a broad range of anti-bacterial activity and advantageous toxicological properties or are prodrugs of compounds having said activity.

Combination-therapy-to-treat-Mycobacterium-diseases

Products Used in this Publication

Catalog NumberCASProduct NamePrice
252260-02-9252260-02-9PosizolidInquiry

Related Products

Catalog NumberCASProduct NamePrice
B0005-1805863466-23-7DehydrodeguelinInquiry
B0084-188763480-41-1NaringeninInquiry
33788-39-5DeodarinInquiry